A retrospective study evaluating impact of treatment beyond progression with immune checkpoint blockade in Hodgkin Lymphoma
Latest Information Update: 20 Jul 2021
At a glance
- Drugs Brentuximab vedotin (Primary) ; Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary) ; Programmed cell death-1 ligand-1 modulators
- Indications Hodgkin's disease
- Focus Therapeutic Use
Most Recent Events
- 20 Jul 2021 New trial record